MeiraGTx Holdings (MGTX) EBITDA Margin (2019 - 2025)
MeiraGTx Holdings (MGTX) posted EBITDA Margin of 24.2% for Q4 2025, up 100.22% on a QoQ basis from 11231.95% in Q3 2025, and up 17142.0% year-over-year from N/an in Q4 2024.
MeiraGTx Holdings (MGTX) EBITDA Margin (2019 - 2025) Analysis & Trends
MeiraGTx Holdings' EBITDA Margin history runs 7 years deep, the most recent figure standing at 24.2% for Q4 2025.
- Quarterly EBITDA Margin rose 17142.0% year-over-year to 24.2% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 105.68% (up 39377.0% YoY) and the FY2025 annual result came in at 140.31%, up 35313.0% from the prior year.
- EBITDA Margin was 24.2% for Q4 2025 at MeiraGTx Holdings, up from 11231.95% in the prior quarter.
- Across five years, EBITDA Margin topped out at 776.38% in Q4 2022 and bottomed at 17241.13% in Q2 2024.
- A 5-year average of 2123.16% and a median of 473.59% in 2022 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2024 — EBITDA Margin slumped 1642800 bps — and 2025, when it surged 1619006 bps.
- MeiraGTx Holdings' EBITDA Margin stood at 36.54% in 2021, then soared by 2224 bps to 776.38% in 2022, then slumped by 41 bps to 454.9% in 2023, then sank by 132 bps to 147.22% in 2024, then soared by 116 bps to 24.2% in 2025.
- Business Quant data shows MGTX's EBITDA Margin at 24.2% in Q4 2025, 11231.95% in Q3 2025, and 1051.07% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 24.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.20% |
| Sep 30, 2025 | -11,231.95% |
| Jun 30, 2025 | -1,051.07% |
| Dec 31, 2024 | -147.22% |
| Sep 30, 2024 | -360.49% |
| Jun 30, 2024 | -17,241.13% |
| Mar 31, 2024 | -6,710.47% |
| Dec 31, 2023 | 454.90% |
| Sep 30, 2023 | -642.01% |
| Jun 30, 2023 | -813.14% |
| Mar 31, 2023 | -952.61% |
| Dec 31, 2022 | 776.38% |
| Sep 30, 2022 | -473.59% |
| Jun 30, 2022 | -220.82% |
| Mar 31, 2022 | -510.10% |
| Dec 31, 2021 | -36.54% |
| Sep 30, 2021 | -324.58% |
| Jun 30, 2021 | -400.37% |
| Mar 31, 2021 | -479.48% |
| Dec 31, 2020 | -348.94% |